Postes actifs de Nicholes Billinton
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Gentronix Ltd.
 Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Directeur des opérations | - | - |
| Fondateur | - | - |
Historique de carrière de Nicholes Billinton
Formation de Nicholes Billinton
| University of Manchester Institute of Science & Technology | Doctorate Degree |
Statistiques
Internationale
| Royaume-Uni | 3 |
Opérationnelle
| Chief Operating Officer | 1 |
| Founder | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Gentronix Ltd.
Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Nicholes Billinton
- Expérience
